Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes

Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders

(2009) Scott A. Schobel et al.   ARCHIVES OF GENERAL PSYCHIATRY

Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia

(2009) S. M. Grauer et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Autoinactivation of Neuronal AMPA Receptors via Glutamate-Regulated TARP Interaction

(2009) Megumi Morimoto-Tomita et al.   NEURON

The supra-additive hyperactivity caused by an amphetamine–chlordiazepoxide mixture exhibits an inverted-U dose response: Negative implications for the use of a model in screening for mood stabilizers

(2009) Michele P. Kelly et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia

(2008) Kuei Y. Tseng et al.   BEHAVIOURAL BRAIN RESEARCH

Chronic G s Signaling in the Striatum Increases Anxiety-Related Behaviors Independent of Developmental Effects

(2008) C. Favilla et al.   JOURNAL OF NEUROSCIENCE

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

(2008) C. J. Schmidt et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Reversal of Oxidative Stress-Induced Anxiety by Inhibition of Phosphodiesterase-2 in Mice

(2008) A. Masood et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Constitutive activation of the G-protein subunit G s within forebrain neurons causes PKA-dependent alterations in fear conditioning and cortical Arc mRNA expression

(2008) M. P. Kelly et al.   LEARNING & MEMORY

Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Gαs, a G-protein subunit genetically linked to schizophrenia

(2008) M P Kelly et al.   MOLECULAR PSYCHIATRY

WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics

(2008) Steven M. Grauer et al.   PSYCHOPHARMACOLOGY

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

(2008) John E. Lisman et al.   TRENDS IN NEUROSCIENCES

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

(2007) Sungho Maeng et al.   BIOLOGICAL PSYCHIATRY